AtlasClear FY2026: Revenue Up 85%, Second Straight Profit, No Dilution

What happened

AtlasClear reported fiscal 2026 revenue of $20.1 million, up 85% year over year, driven by a surge in stock locate revenue to $6.8 million from $0.3 million, with non-commission sources now 54% of total revenue. The company posted its second consecutive year of positive GAAP net income at $2.0 million, though this included non-cash fair-value gains, and cash more than doubled to $15.4 million while stockholders' equity swung from a $6.8 million deficit to a positive $21.1 million. AtlasClearing's net capital increased 29% to $14.4 million, and five new correspondent broker-dealers were signed with a sixth after year-end, all achieved without at-the-market or equity line financing. This marks a dramatic turnaround from the company's position a year prior, when going concern doubts, a stockholders' deficit, and reliance on dilutive financing were major concerns. The results suggest that AtlasClear is executing on its plan and achieving organic growth, though the sustainability of non-cash fair-value gains and the competitive environment remain watch items.

Implication

Investors should note that AtlasClear has addressed key prior concerns: it is now profitable, has positive equity, and is growing without dilution, which removes a major overhang. The growth in stock locate revenue, a high-margin business, diversifies income and reduces reliance on commission-based clearing. However, GAAP net income includes non-cash fair-value gains that may not repeat, so we will scrutinize operating cash flow and adjusted earnings in future quarters. The addition of correspondent broker-dealers suggests client traction, but we need to see revenue retention and cross-selling into banking services if the Commercial Bancorp deal progresses. Overall, we view the stock as more investable now, but we maintain a critical eye on execution and market conditions.

Thesis delta

Our previous NEUTRAL/HOLD stance was based on financing risk, going concern doubt, and unproven execution. The fiscal 2026 results directly address these: positive net income, improved balance sheet, and growth without dilution indicate execution success and reduced financial risk. We shift to a BUY/OVERWEIGHT stance, contingent on continued organic growth and evidence that non-cash gains are not masking weak cash generation.